Author:
Heo Young-A.,Syed Yahiya Y.,Keam Susan J.
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. National Comprehensive Cancer Network. Acute lymphoblastic leukemia (NCCN clinical practice guidelines in oncology). 2018.
http://www.nccn.org/
. Accessed 4 Mar 2019.
2. Hoelzer D, Bassan R, Dombret H, et al. Acute lymphoblastic leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(Suppl 5):v69–82.
3. Asselin BL. The three asparaginases: comparative pharmacology and optimal use in childhood leukemia. In: Kaspers GJL, Pieters R, Veerman AJP, editors. Drug resistance in leukemia and lymphoma III Advances in experimental medicine and biology. Boston: Springer; 1999. p. 621–9.
4. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166–78.
5. Silverman LB, Supko JG, Stevenson KE, et al. Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia. Blood. 2010;115(7):1351–3.
Cited by
74 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献